INDICATION
For the treatment of –
Internal and external haemorrhoids
Haemorrhoids post-partum
Anal pruritus, peri-anal eczema, anal fissures and proctitis
Post-haemorrhoidectomy application to relieve pain and discomfort
DOSAGE & ADMINISTRATION
Ointment: Apply the ointment in a small quantity with the finger, on the painful or pruritic area, morning and evening and after each stool. For deep application attach
cannula/applicator (Supplied) to tube, insert to full extent and squeeze tube gently from lower end whilst withdrawing.
Suppository: A suppository is inserted morning and evening, and after each stool.
CONTRAINDICATION
Known hypersensitivity to any of the four ingredients. Corticosteroids have been shown to be teratogenic in animals following dermal application. As these agents are
absorbed percutaneously, teratogenicity following topical application cannot be excluded. Therefore this product should not be used during pregnancy. Topical
corticosteroid preparations are contraindicated in the treatment of herpes simplex, vaccinia or varicella, or tuberculous infection of the anal region.
PRECAUTION
Discontinue use if sensitization occurs. Other specific measures against infections, allergy, and other causal factors must not be neglected. The possibility, however rare,
that prolonged use of this preparation might produce systemic corticosteroid effects, should be borne in mind. Patients should be advised to inform subsequent
physicians of the previous use of hydrocortisone.
SIDE-EFFECTS
Long-term continuous treatment with topical corticosteroids should be avoided as far as possible as this may cause atrophic changes in the skin leading to thinning, loss
of elasticity, dilatation of superficial blood vessels, telangiectasia and ecchymoses. These changes are particularly likely to occur when occlusive dressings are used.
Systemic absorption of topically applied corticosteroids may occur, particularly under the following conditions: when large quantities are used or when application is
made to wide areas of the body, or to damaged skin; when potent topical corticosteroids are used, and when the occlusive dressing technique is applied. Depression of
the hypothalamic-pituitary-adrenal axis with consequent suppression of the adrenal gland may occur. These effects are most likely to be severe in children. Growth may
be retarded and a Cushingoid state may be produced. Benign intracranial hypertension has been rarely reported.
DRUG INTERACTION
Proper data is not available.
USE IN PREGNANCY
Pregnancy: The safe use of topical corticosteroids during pregnancy has not been fully established. Therefore, during pregnancy, they should not be used unnecessarily
on extended areas, in large amounts or for prolonged periods of time.
Reviews
There are no reviews yet.